Exagen (XGN)

Exagen (XGN) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• XGN last traded at $8.59, -1.26% on the day.
• Exagen: market cap $208.10M, P/E -10.2, revenue $71.12M over the last four quarters, next earnings 2026-11-10.
• Over the past year XGN returned -26.96%; year to date 41.28%.

Updated 2026-11-03 01:46 UTC